Explore daily insights on
AKTX volume surges to 29x its shares outstanding in an 84% daily rally
- Akari Therapeutics witnessed a massive retail-driven volume spike and price surge during the May 22 session.
- Trading volume reached 33.81 million shares, representing 104.1 times its 20-day average and 29.5 times its total shares outstanding.
- This extreme trading activity demonstrates intense short-term momentum and high volatility in low-float biotech stocks.
Supporting datasets
Supporting queries
To surface this insight, Baselight ran 5 queries across its structured data. Each one is reproducible — open it, read the SQL, and rerun it yourself.
Conclusion
Key numbers: 33,808,000 volume on May 22 vs. 20-day average of 324,712 and 1,144,588 shares outstanding; stock rose from $9.92 open to $18.27 close (+84.17%).